Ab­b­Vie, No­vo Nordisk TV ads gen­er­ate most search­es in first half of 2022, ad track­er finds

Most phar­ma TV com­mer­cials in­clude a link at the end of the ad, of­fer­ing a web­site link for view­ers who want more in­for­ma­tion. It turns out mil­lions of them do. So far in 2022, Ab­b­Vie, No­vo Nordisk and As­traZeneca are lead­ing the phar­ma pack with the most en­gage­ments gar­nered, ac­cord­ing to da­ta for the first half of 2022 from TV ad track­er EDO.

Ab­b­Vie’s Al­ler­gan Vuity eye­drops for age-re­lat­ed blur­ry vi­sion drove the most search­es among phar­ma TV ad­ver­tis­ing, gen­er­at­ing 3.43 mil­lion search­es af­ter ad runs. That’s more than dou­ble the to­tal for the next searched TV ad at No. 2, No­vo Nordisk’s Ozem­pic, which notched 1.7 mil­lion, in EDO’s re­search.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.